Nkarta, Inc.
NKTX Nasdaq· Pharmaceutical Preparations
Last close · Oct 27, 2026
$1.70
KIRA · Stoqly’s AI analyst, in plain words
- Nkarta, Inc. had $0.0M of revenue in fiscal 2025.
- Nkarta, Inc. lost $104M in fiscal 2025.
- Free cash flow was −$89.9M in fiscal 2025, — of revenue.
Market cap
$127M
P/E
—
Revenue
$0.0M
Net income
−$104M
Free cash flow
−$89.9M
Operating margin
—
Nkarta, Inc. in 30 seconds · fiscal 2025
Does it make a profit?
−$104M
No. It lost money last year.
How healthy are the accounts?
1 / 7
Weak. It passes 1 of 7 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Nkarta, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 25, 2026
- Legal name
- Nkarta, Inc.
- CIK
- 0001787400
Nkarta, Inc. · NKTX
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | — | — | — | $0.0M | $0.0M |
| Net income | −$86.1M | −$114M | −$118M | −$109M | −$104M |
| Diluted EPS | −$2.62 | −$2.61 | −$2.40 | −$1.60 | −$1.41 |
| Cash | |||||
| Cash from operations | −$67.9M | −$57.0M | −$86.2M | −$99.7M | −$88.7M |
| Capital expenditure | $5.0M | $47.1M | $28.1M | $4.4M | $1.2M |
| Free cash flow | −$73.0M | −$104M | −$114M | −$104M | −$89.9M |
| Share count change | 95.5% | 32.8% | 12.3% | 38.5% | 9.0% |
| Debt and strength | |||||
| Cash and short-term investments | $238M | $352M | $248M | $267M | $276M |
| Shareholders' equity | $251M | $372M | $273M | $408M | $312M |
| Current ratio | 19.0x | 16.4x | 10.8x | 14.4x | 12.7x |
| Returns and quality | |||||
| Return on equity | −30.1% | −36.5% | −36.4% | −31.9% | −28.9% |
| Return on tangible equity | −34.3% | −30.6% | −43.0% | −26.7% | −33.3% |
| Piotroski F-score | — | — | — | — | 1 |
| Altman Z'' | 12.5 | 4.7 | 0.6 | 2.7 | 0.5 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.1M
2 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Nkarta, Inc. · NKTX
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $1.70 a share, the company is worth $127M.
Source: SEC EDGAR XBRL filings (CIK 0001787400). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.